Kulika WeizmanDecoding AI’s True Impact on Drug DevelopmentTraditionally, drug discovery and development have been viewed as binary: a drug either progresses through clinical trials and approval or…Jul 21Jul 21
Kulika WeizmaninCreative VenturesWhy we invested in 3E NanoCreative Ventures invested in 3E Nano’s Series Seed in late 2022. Now the news on the closing is official, and we’re thrilled to welcome 3E…Apr 4, 2023Apr 4, 2023
Kulika WeizmaninCreative Ventures3 Takeaways from the 2023 JP Morgan Healthcare ConferenceDespite storms, hail, and flash flood warnings, San Francisco hosted the JP Morgan Healthcare Conference live and in person last week —…Jan 16, 2023Jan 16, 2023
Kulika WeizmaninCreative VenturesReflecting on BioFuture & value-based careI had the pleasure of speaking at the BioFuture in New York City earlier this November. During our panel, while discussing ways to innovate…Dec 15, 2022Dec 15, 2022
Kulika WeizmaninCreative VenturesThe Do’s and Dont’s of Sharing Proprietary InformationDue diligence comes naturally to investors-or at least it should. For our team, investing in early-stage companies means due diligence on…Sep 23, 2022Sep 23, 2022
Kulika WeizmaninCreative VenturesDiversity in clinical trials: necessary but insufficientOne of our three main investment areas at Creative Ventures is tackling rising healthcare costs. It’s disheartening to see just how broken…Aug 10, 2022Aug 10, 2022
Kulika WeizmaninCreative VenturesTapping into the power of natureThe ambition to adapt, modify, and even bend nature at times sets humans apart from other species. It’s not exactly natural for edible…Mar 23, 2022Mar 23, 2022
Kulika WeizmaninCreative VenturesThe importance of empirical evidence for early-stage deeptech companiesIn light of the latest news on Theranos, and a seemingly endless amount of swift capital pouring into deeptech startups today, how can…Jan 12, 2022Jan 12, 2022
Kulika WeizmaninCreative VenturesThe Carbon EquationVCs are no strangers to the boom and bust cycles of industries and underlying technologies. Obviously, it’s great for the returns if one…Nov 15, 2021Nov 15, 2021
Kulika WeizmaninCreative VenturesUsing Diagnostic Innovation to Measure What MattersCreative Ventures invested in Rhaeos’ Series Seed round in July 2021. Rhaeos is a clinical-stage medical device company developing…Oct 25, 2021Oct 25, 2021
